Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07524829) titled 'Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Azienda Sanitaria Locale di Asti
Condition:
Breast Cancer
Drug-Related Side Effects and Adverse Reactions
Chemotherapy Toxicity
Treatment Adherence
Treatment-Related Toxicity
Intervention:
Behavioral: Structured Telenursing Follow-up
Recruitment Status: Recruiting
Phase: ...